Related Experiment Video
Updated: Aug 9, 2025
09:56
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
702
mRNA-From COVID-19 Treatment to Cancer Immunotherapy
1Independent Researcher, 13505 Berlin, Germany.
Biomedicines
|February 25, 2023
Summary
Messenger RNA (mRNA) technology, proven in COVID-19 vaccines, is advancing cancer immunotherapy. This review covers antigen selection, mRNA optimization, and formulation for effective tumor treatment strategies.
Area of Science:
- Biotechnology
- Immunology
- Oncology
Background:
- Messenger RNA (mRNA) technology has revolutionized vaccine development, notably during the COVID-19 pandemic.
- Its potential is now being explored for therapeutic applications, particularly in cancer treatment.
Purpose of the Study:
- To provide a comprehensive overview of mRNA applications in cancer immunotherapy.
- To discuss key considerations for developing effective mRNA-based cancer vaccines.
Main Methods:
- Review of scientific literature and clinical trial data.
- Analysis of mRNA molecule optimization strategies (stability, efficacy, tolerability).
- Evaluation of formulation and administration route selection.
Main Results:
- Detailed examination of antigen selection, including tumor-associated antigens, tumor-specific antigens, and neoantigens.
- Discussion on optimizing mRNA constructs for enhanced therapeutic outcomes.
- Summary of current clinical trials investigating mRNA vaccines for cancer therapy.
Conclusions:
- mRNA technology holds significant promise for developing novel cancer immunotherapies.
- Further research and clinical trials are essential to fully realize the potential of mRNA in oncology.
Related Concept Videos
01:27Tumor Immunotherapy
611
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
611
01:30Cancer Vaccines
468
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
468
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K